Detect, Inc.
Developer of a multiplex molecular diagnostic platform focused on women’s health. The company designs a compact, sample-to-answer device and associated reagents and assays to deliver rapid molecular results at the point of care. Leadership experience reported in molecular diagnostics, assay development, clinical and regulatory affairs, supply chain, and commercialization.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Compact multiplex molecular diagnostic device
A compact device engineered to perform multiplex molecular assays with a sample-to-answer workflow intended for clinical office environments.
Compact multiplex molecular diagnostic device
A compact device engineered to perform multiplex molecular assays with a sample-to-answer workflow intended for clinical office environments.
Services
Provision of an on-site multiplex molecular testing solution designed to deliver rapid results during clinical visits.
Custom assay design and reagent development, including AI-enabled primer design for molecular diagnostics.
Clinical research planning and regulatory strategy support for diagnostic product development and approval.
Operational expertise for supply chain, distribution, and market access of diagnostic devices and consumables.
Provision of an on-site multiplex molecular testing solution designed to deliver rapid results during clinical visits.
Custom assay design and reagent development, including AI-enabled primer design for molecular diagnostics.
Clinical research planning and regulatory strategy support for diagnostic product development and approval.
Operational expertise for supply chain, distribution, and market access of diagnostic devices and consumables.
Expertise Areas
- Molecular diagnostics
- Point-of-care testing
- Assay development
- Clinical research and regulatory strategy
Key Technologies
- Multiplex molecular assays
- Point-of-care sample-to-answer workflows
- AI-driven primer design
- Custom reagent chemistries